1. Home
  2. MI vs HAE Comparison

MI vs HAE Comparison

Compare MI & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NFT Limited

MI

NFT Limited

HOLD

Current Price

$5.45

Market Cap

58.3M

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$57.62

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MI
HAE
Founded
2009
1971
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.3M
3.9B
IPO Year
N/A
1991

Fundamental Metrics

Financial Performance
Metric
MI
HAE
Price
$5.45
$57.62
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$86.00
AVG Volume (30 Days)
10.7K
1.1M
Earning Date
05-07-2026
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.84
EPS
N/A
3.65
Revenue
$662,718.00
$1,318,275,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.86
P/E Ratio
N/A
$15.78
Revenue Growth
N/A
N/A
52 Week Low
$1.57
$47.32
52 Week High
$5.79
$87.32

Technical Indicators

Market Signals
Indicator
MI
HAE
Relative Strength Index (RSI) 73.87 23.44
Support Level $3.80 $55.95
Resistance Level $4.93 $60.50
Average True Range (ATR) 0.38 2.35
MACD 0.17 -0.58
Stochastic Oscillator 79.40 15.70

Price Performance

Historical Comparison
MI
HAE

About MI NFT Limited

NFT Ltd operates an online electronic platform for offering and trading artwork. Through its platform, the company allows artists/art dealers/owners to access a much bigger art trading market where artists can engage with a wide range of investors. Its platform also invests in high-end artwork accessible to ordinary people without financial resources. The company's trading platforms comprise the sale of calligraphies and paintings, jewelry, and precious stones. It generates revenue in the form of services in connection with the offering and trading of artwork on its system, consisting of listing fees, trading commissions, and management fees.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: